This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
